Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

By M. J. van den Bent, A. Brandes, M. Taphoorn, J. Kros, M. Kouwenhoven, Jean-Yves Delattre, H. Bernsen, M. Frénay, C. Tijssen, W. Grisold and 9 more. Journal of Clinical Oncology, 2013

1,120 citations recorded by the source corpus.

Subfields: Genetics, Neurology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/e57340f9728db2fedc99ac90418ad07ee4cbba30

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Guido Reifenberger

Citations in the corpus

• Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma (2016, neutral): “Astrocytoma features dominant 19 (15) 19 (15)”
• Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas (2018, neutral): “4) to prevent overfitting.”
• Glioma Subclassifications and Their Clinical Significance (2017, background): “The EORTC 26951 from Europe presented similar chemosensitivity and favorable prognosis with 1p/19q co-deleted tumors [28].”
• High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014, background): “Long-term follow-up (10 years) of randomised clinical trials demonstrated prolonged survival with (neo)adjuvant PCV chemotherapy (procarbazine, lomustine [CCNU], vincristine) in newly diagnosed anaplastic oligoastrocytoma and oligodendroglioma [40, 41], but benefit was mainly present in prognostical”
• Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas (2015, neutral): “Grade III 33 (12) 4 (5) 20 (14) 9 (16)”
• Glioblastoma: pathology, molecular mechanisms and markers (2015, background): “1 3 patients), 1p and 19q co-deletions in anaplastic oligodendrogliomas, and IDH1/2 mutations, now play major roles in tumor diagnostics and/or clinical decision making [21, 105, 164, 174].”